You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLK Buy Disclosure
Sukhtian Ghiath M. · SEC Form 4 · Filed Aug 14, 2026
Buy
Calculated transaction value
$0
Sukhtian Ghiath M. Director / Ten Percent Owner
OTLK
Outlook Therapeutics
OTLK
Transaction date
Aug 12, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 2 days later
OTLK daily price context
Close on/before transaction
$1.1
Aug 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Warrants (right to buy) on Common Stock
- Quantity / price
- 2,525,252 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0000899140-26-000894
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$2.5M
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Outlook Therapeutics, Inc. OTLK | Buy | Aug 12, 2026 | $2.5M |
| Outlook Therapeutics, Inc. OTLK Current | Buy | Aug 12, 2026 | $0 |